Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Julian Thalhammer(University of Freiburg), Pauline Brosselin, David Edgar(Queen's University Belfast), Alenka Gagro(University of Zagreb), Rabab El Hawary(Cairo University), Julie Smet, Marina Kojić, Uwe Wintergerst(Centre National de la Recherche Scientifique), Sohilla Lotfy, Anna Šedivá(Charles University), Markus G. Seidel(Medical University of Graz), Aisha Elmarsafy(Cairo University), Alain Fischer(Inserm), Alia Eldash, Stephan Rusch, Svetlana Sharapova(Belarusian Research Center For Pediatric Oncology and Hematology), Lukas Wisgrill(Universität Innsbruck), Ali Sobh(Children's Hospital Mansoura University), Stephan Ehl(University Medical Center Freiburg), Isabelle Meyts(KU Leuven), Fine Roosens, Darko Richter, Alexandra Nieters, Lukas Gasteiger(Innsbruck Medical University), Andrea Schroll(Innsbruck Medical University), Tessa Kerre(Ghent University Hospital), Kaan Boztuǧ(Forschungszentrum Jülich), Gerhard Kindle(University of Freiburg), Nizar Mahlaoui(Hôpital Necker-Enfants Malades), Safa Meshaal, Zelimir Pavle Eric, Lisa Göschl(Medical University of Vienna), Elisabeth Förster‐Waldl, Jean‐Christophe Goffard(Université Libre de Bruxelles), Tomáš Milota(Charles University), Bodo Grimbacher(University Medical Center Freiburg), Eva Hlaváčková, Matthew Buckland(Barts Health NHS Trust), Veneta Milenova, Zita Chovancová, Ulrike Demel, Mikko Seppänen(University of Helsinki), Dalia Abd Elaziz, Shereen M. Reda, Radwa Alkady, Juergen Brunner, Filomeen Haerynck(Ghent University Hospital), Nermeen Galal(Cairo University), Jiří Litzman(Masaryk University)
Cited by 175
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k